Cancer Prevention Group Blog

Cancer Prevention Group Blog

Research Today, Cancer Prevention Tomorrow

sensitivity

Towards cervical cancer elimination: DNA methylation as a triage strategy

October 21, 2020 Guest Author 0

Today we discuss with Professor Gloria I. Sanchez her latest research into DNA methylation as a triage strategy for women testing HPV positive at the […]

A blood test to find over 50 cancers could be the future of early diagnosis

April 9, 2020 Guest Author 0

This blog was written by Mairéad Lyons. Mairéad is a Senior Consultant to YouScreen the HPV Self-Sampling study.  She has been working in healthcare for […]

Artificial Intelligence in breast cancer screening – part 4: personalising screening

January 23, 2020 Peter Sasieni 0

In the final of our posts regarding the recent major international evaluation of AI in breast cancer screening, we consider how AI could be used […]

Artificial Intelligence in breast cancer screening – part 3: implications for the UK

January 15, 2020 Peter Sasieni 0

In the third of our posts regarding the recent major international evaluation of AI in breast cancer screening, we consider what might be the implications […]

breast cancer

Artificial Intelligence in breast cancer screening – part 2: international differences

January 8, 2020 Peter Sasieni 0

Previously we reported on a major study evaluating AI as a tool to identify breast cancer on mammography. The results were impressive. In the UK, […]

Artificial Intelligence in breast cancer screening – part 1: are computers developing 20/20 vision?

January 1, 2020 Peter Sasieni 1

Despite many technological advances in mammographic imaging over the last century, breast cancer screening is largely the same as it was when first studied 60 […]

Which screening guidelines are woefully inadequate?

September 20, 2019 Peter Sasieni 0

Following a high-profile article calling for a change in guidelines to make it easier for African Americans to be eligible for lung cancer screening, Prof […]

Screening iconoclasm series: Is it time for cancer screening to become non-binary?

March 22, 2019 Peter Sasieni 0

In our final iconoclasm series post, Peter Sasieni explores the merits of making cancer screening non-binary. The classic paradigm for diagnostic testing and medical screening […]

Screening iconoclasm series: Could you be more specific about what you mean by specificity?

March 15, 2019 Peter Sasieni 0

In this post, Peter Sasieni argues that it is time to be more specific about our definitions of specificity and false positive tests. How will […]

From theory to practice: HPV testing in cervical screening really does work!

February 7, 2019 Alejandra Castanon 4

After months of eager anticipation, the results from the English HPV implementation pilot have been published. Compared to current screening HPV testing detected 50% more […]

Screening iconoclasm series: Don’t be overly sensitive about sensitivity

January 25, 2019 Peter Sasieni 2

In this post, Peter Sasieni argues that sensitivity is over-rated. It is the first of a series of posts on “Screening Iconoclasm” in which we […]

Posts navigation

1 2 »

Welcome to the King’s Cancer Prevention blog

This blog is supported by the Cancer Research UK Cambridge Centre Early Detection Programme

Cancer Prevention: About us

We are a group of epidemiologists and population researchers studying the causes of or early events in the development of cancer. Our aim is to be able to interfere and prevent cancer or diagnose it whilst still easy to treat.

Contact us at cancerprev@kcl.ac.uk

Follow us on Social Media

 

TWITTER FEED

Tweets by CancerPrev_KCL

Latest Posts, Tags & Comments
  • Pathology and Artificial Intelligence in BEST3
  • Bowel cancer surveillance for high-risk patients in the time of COVID-19: What have we learned?
  • Headline findings of the BEST3 Trial
  • Beyond trust: collective understanding of the common good and patient data
  • Medical research and the double-edged sword of data protection
  • Medical research and the common law of confidentiality
  • Can prediction models reduce racial/ethnic disparities in lung screening eligibility criteria?
  • Cancer Prevention Group’s 2020 Christmas reading list
  • An interview with: Dr Stuart Griffiths, Director of Research & Services at Yorkshire Cancer Research
  • Achieving cervical cancer elimination requires collective action from civil society
Barrett’s oesophagus Best 3 cancer prevention cancer screening cervical cancer cervical screening cervix Clinical research network COVID-19 Cytosponge™ ethics five minutes with HPV HPV primary screening mammography medical research Oesophageal cancer public health public policy quality assurance Sasieni scandal screening sensitivity Upper GI
  • Betty Lakop: I had the privilege of working with Louise in colposcopy clinic in St. Marys Hospital. What I will never forget…
  • Pink Promise India: Great share! Totally agree with you. Early detection of breast cancer through mammography screening leads to numerous treatment options as…
  • Beyond trust: collective understanding of the common good and patient data – Cancer Prevention Group Blog: […] the previous post, we mentioned Use My Data and Understanding Patient Data as examples of efforts to bring […]
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2021 | WordPress Theme by MH Themes